Global Human Vaccine Market 2018-2022
About Human Vaccine
Vaccines are biological preparations used to confer active acquired immunity against a host-causing disease. Vaccines have been impacting the global health scenario by reducing disease incidence, mortality rates, and life expectancy.
Technavio’s analysts forecast the Global Human Vaccine Market to grow at a CAGR of 7.73% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the human vaccine market. To calculate the market size, the report considers the revenue generated from the retail sales of human vaccines across the globe.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report - Global Human Vaccine Market 2018-2022
Technavio recognizes the following companies as the key players in the global human vaccine market: GlaxoSmithKline, Merck, Pfizer, and Sanofi.
Commenting on the report, an analyst from Technavio’s team said: “One trend affecting this market is the varied demand for vaccines in high-income and developing countries. The demand for novel vaccines is high in developing economies as they receive financial support.”
According to the report, one driver influencing this market is the increase in investments in vaccine segment. High investments by vaccine manufacturers are necessary to develop a wide variety of vaccines, reduce product and process complexity, and maintain aggressive timelines for vaccine development and life cycle management.
Further, the report states that one challenge affecting this market is the rising pricing pressure. Leading companies have been under pressure from medical associations to lower the price of vaccines so that governments can procure them for public immunization programs.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook